Company / Cash per Share
Lipocine Inc. Cash per Share History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.97
FY2025
5-year range
$0.04 / $1.17
FY2021-FY2025
Trend
-16.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 9 years, ranging from $0.04 in FY2022 to $1.21 in FY2013.
Based on SEC 10-K filings.
0.97 in FY2025 with a 5-year CAGR of +13.8%.
Improved from $0.91 to $0.97 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +201.1%
- 5-Year CAGR
- +13.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 16.6% year-over-year.
- Peak cash per share was recorded in FY2013.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.97 | -16.6% |
| FY2024 | $1.17 | +28.1% |
| FY2023 | $0.91 | +2456.2% |
| FY2022 | $0.04 | -15.4% |
| FY2021 | $0.04 | -91.7% |
| FY2020 | $0.51 | +14.0% |
| FY2019 | $0.45 | +17.9% |
| FY2018 | $0.38 | -68.5% |
| FY2013 | $1.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026